Related Experiment Video
Updated: Mar 23, 2026

10:18
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
14.3K
Association between left ventricular function and paraprotein type in patients with multiple myeloma.
Jeong-Eun Yi1,2, Sung-Eun Lee2, Hae-Ok Jung2
1Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Seoul, Korea.
The Korean Journal of Internal Medicine
|April 7, 2016
Summary
Elevated serum M protein correlates with diastolic dysfunction in multiple myeloma (MM), while increased free light chain lambda (FLC-λ) is linked to reduced left ventricular systolic function in MM patients.
Area of Science:
- Cardiology
- Hematology
- Oncology
Background:
- Multiple myeloma (MM) can cause cardiac damage, but the specific impact of different monoclonal (M) protein types remains unclear.
- Understanding the relationship between M protein levels and cardiac function is crucial for managing MM patients.
Purpose of the Study:
- To investigate the association between serum M protein levels and echocardiographic measures of cardiac structure and function in MM patients.
- To differentiate the cardiac effects based on the type of M protein (intact M protein vs. free light chains).
Main Methods:
- Echocardiography was performed on 184 MM patients undergoing pre-transplant screening.
- Serum levels of intact immunoglobulin M protein and free light chains (kappa/lambda) were measured.
Main Results:
- In non-light chain MM (non-LCMM), M protein correlated with left atrial volume index, E/e', and systolic pulmonary arterial pressure.
- In light chain MM (LCMM), FLC-λ correlated with left ventricular ejection fraction, end-systolic dimension, and end-systolic volume.
- Serum M protein and hematocrit were independent predictors of left atrial volume index in non-LCMM patients.
Conclusions:
- Increased serum M protein is associated with left ventricular diastolic dysfunction in MM.
- Increased serum FLC-λ concentration correlates with impaired left ventricular systolic function.
- The type of paraprotein influences the effect of M protein on left ventricular function in MM.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
652
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
652
Cardiomyopathy IV: Restrictive Cardiomyopathy
761
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
761
Cardiomyopathy V: Interprofessional Care
605
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
605

